Studies on antifungal agents. 18. In vitro activity of 5,5-disubstituted-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methy lisoxazol idines and related compounds. 1988

G B Mullen, and T R DeCory, and S D Allen, and J T Mitchell, and V St Georgiev
Department of Organic Chemistry, Pennwalt Corporation, Rochester, N.Y.

The in vitro antifungal activity of a series of novel 5,5-disubstituted-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methyli soxazolidines and related compounds against Trichophyton rubrum, Aspergillus fumigatus and Candida albicans was studied. The screening was performed in solid agar cultures and some structure-activity relationships involving the C-5-substitution pattern are discussed.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics

Related Publications

G B Mullen, and T R DeCory, and S D Allen, and J T Mitchell, and V St Georgiev
January 1990, Arzneimittel-Forschung,
G B Mullen, and T R DeCory, and S D Allen, and J T Mitchell, and V St Georgiev
January 1988, Annals of the New York Academy of Sciences,
G B Mullen, and T R DeCory, and S D Allen, and J T Mitchell, and V St Georgiev
January 1988, Annals of the New York Academy of Sciences,
G B Mullen, and T R DeCory, and S D Allen, and J T Mitchell, and V St Georgiev
January 1988, Annals of the New York Academy of Sciences,
G B Mullen, and T R DeCory, and S D Allen, and J T Mitchell, and V St Georgiev
January 1988, Annals of the New York Academy of Sciences,
G B Mullen, and T R DeCory, and S D Allen, and J T Mitchell, and V St Georgiev
January 1988, Annals of the New York Academy of Sciences,
G B Mullen, and T R DeCory, and S D Allen, and J T Mitchell, and V St Georgiev
February 1990, Arzneimittel-Forschung,
G B Mullen, and T R DeCory, and S D Allen, and J T Mitchell, and V St Georgiev
January 1988, Annals of the New York Academy of Sciences,
G B Mullen, and T R DeCory, and S D Allen, and J T Mitchell, and V St Georgiev
January 1988, Annals of the New York Academy of Sciences,
G B Mullen, and T R DeCory, and S D Allen, and J T Mitchell, and V St Georgiev
December 1988, Journal of pharmaceutical sciences,
Copied contents to your clipboard!